Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The drug which has got approval to treat moderate to severe Covid complications will be manufactured as an intravenous injection at Biocon's Bengaluru plant
It is an inflammatory skin disease that can affect different parts of the body such as elbow, knees, scalp and more.